Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.
Total raised: $28M
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 12.04.2012 | Series B | $10M | - | finsmes.co... |
| 17.02.2010 | - | $18M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 13.04.2012 | Tioga Phar... | Tioga Pharmaceuticals, Inc., a... | funding S... | - | finsmes.co... |
| 12.04.2012 | Tioga ... | San Diego-based Tioga Pharmace... | - | - | socaltech.... |
| 17.02.2010 | Tioga Phar... | San Diego-based Tioga Pharmace... | - | - | sdbj.com/n... |
| 17.02.2010 | Tioga Phar... | Tioga Pharmaceuticals, Inc., a... | USA ventu... | - | finsmes.co... |